{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:05:57Z","timestamp":1711670757382},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1985,11]]},"DOI":"10.1212\/wnl.35.11.1644","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T12:34:11Z","timestamp":1336912451000},"page":"1644-1644","update-policy":"http:\/\/dx.doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Parkinson's disease and hypertension"],"prefix":"10.1212","volume":"35","author":[{"given":"J. L.","family":"Montastruc","sequence":"first","affiliation":[{"name":"From the Laboratoire de Pharmacologie Me\u0301dicale et Clinique, Faculte\u0301 de Me\u0301decine (Prof. Montastruc), Service de Me\u0301decine Interne, C.H.U. Purpan (Dr. Chamontin), and Service de Neurologie, C.H.U. Purpan (Pr. Rascol). Toulouse, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Chamontin","sequence":"additional","affiliation":[{"name":"From the Laboratoire de Pharmacologie Me\u0301dicale et Clinique, Faculte\u0301 de Me\u0301decine (Prof. Montastruc), Service de Me\u0301decine Interne, C.H.U. Purpan (Dr. Chamontin), and Service de Neurologie, C.H.U. Purpan (Pr. Rascol). Toulouse, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rascol","sequence":"additional","affiliation":[{"name":"From the Laboratoire de Pharmacologie Me\u0301dicale et Clinique, Faculte\u0301 de Me\u0301decine (Prof. Montastruc), Service de Me\u0301decine Interne, C.H.U. Purpan (Dr. Chamontin), and Service de Neurologie, C.H.U. Purpan (Pr. Rascol). Toulouse, France."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.35.11.1644","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T16:22:38Z","timestamp":1711642958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.35.11.1644"}},"subtitle":["Chronic bromocriptine treatment"],"short-title":[],"issued":{"date-parts":[[1985,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1985,11]]}},"alternative-id":["10.1212\/WNL.35.11.1644"],"URL":"https:\/\/doi.org\/10.1212\/wnl.35.11.1644","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,11]]}}}